Arovella Therapeutics Ltd (ALA)

Sydney
0.031
0.000(0.00%)
  • Volume:
    1,321,501
  • Bid/Ask:
    0.031/0.032
  • Day's Range:
    0.031 - 0.032

ALA Overview

Prev. Close
0.031
Day's Range
0.031-0.032
Revenue
299.66K
Open
0.032
52 wk Range
0.02-0.055
EPS
-0.016
Volume
1,321,501
Market Cap
21.47M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
981,561
P/E Ratio
-2.23
Beta
-0.853
1-Year Change
-31.91%
Shares Outstanding
670,850,808
Next Earnings Date
26 Feb 2023
What is your sentiment on Arovella Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Arovella Therapeutics Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Arovella Therapeutics Ltd Analysis

Arovella Therapeutics Ltd Company Profile

Arovella Therapeutics Ltd Company Profile

Employees
27
Market
Australia

Arovella Therapeutics Limited, a biotechnology company, focuses on the development of therapies for the treatment of cancer and conditions that affect the central nervous system in Australia and internationally. Its product pipeline includes ZolpiMist, an oral spray of zolpidem tartrate to treat short-term insomnia, which is marketed under the brand name of Ambien or Stilnox; invariant natural killer T (iNKT), a cell therapy platform to treat blood cancer; OroMist, an oro-mucosal technology that delivers a range of drug classes through the cheeks, gums, tongue, or floor of the mouth; and Anagrelide to treat cancer. The company also develops oral sprays to treat migraine headaches, motion sickness, and drug-resistant epilepsy. It has a collaborative research agreement with Imperial College London. The company was formerly known as Suda Pharmaceuticals Ltd and changed its name to Arovella Therapeutics Limited in October 2021. Arovella Therapeutics Limited was incorporated in 1999 and is headquartered in Osborne Park, Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuySell
Technical IndicatorsSellStrong SellStrong SellNeutralStrong Sell
SummaryStrong SellStrong SellStrong SellNeutralStrong Sell